Works matching DE "EXEMESTANE"

Results: 89
    1
    2

    Cancer Diagnostic and Predictive Biomarkers 2018.

    Published in:
    BioMed Research International, 2019, p. 1, doi. 10.1155/2019/3879015
    By:
    • Buonaguro, Franco M.;
    • Caposio, Patrizia;
    • Tornesello, Maria Lina;
    • De Re, Valli;
    • Franco, Renato
    Publication type:
    Article
    3
    4
    5
    6

    Early Changes of the Standardized Uptake Values (SUV max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3314, doi. 10.3390/cancers12113314
    By:
    • Sirico, Marianna;
    • Bernocchi, Ottavia;
    • Sobhani, Navid;
    • Giudici, Fabiola;
    • Corona, Silvia P.;
    • Vernieri, Claudio;
    • Nichetti, Federico;
    • Cappelletti, Maria Rosa;
    • Milani, Manuela;
    • Strina, Carla;
    • Cervoni, Valeria;
    • Barbieri, Giuseppina;
    • Ziglioli, Nicoletta;
    • Dester, Martina;
    • Bianchi, Giulia Valeria;
    • De Braud, Filippo;
    • Generali, Daniele
    Publication type:
    Article
    7

    Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10).

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3265, doi. 10.3390/cancers12113265
    By:
    • Lee, Soohyeon;
    • Im, Seock-Ah;
    • Kim, Gun Min;
    • Jung, Kyung Hae;
    • Kang, Seok Yun;
    • Park, In Hae;
    • Kim, Jee Hyun;
    • Lee, Kyoung Eun;
    • Ahn, Hee Kyung;
    • Lee, Moon Hee;
    • Kim, Hee-Jun;
    • Kim, Han Jo;
    • Lee, Jong In;
    • Koh, Su-Jin;
    • Park, Yeon Hee
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Paget's Disease of the Male Breast.

    Published in:
    International Journal of Gerontology, 2022, v. 16, n. 4, p. 407, doi. 10.6890/IJGE.202210_16(4).0020
    By:
    • Shih-Ting Chen;
    • Chien-Ming Chao;
    • Wei-Ting Lin
    Publication type:
    Article
    15

    Evaluating the 21-gene assay Recurrence Score as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 607, doi. 10.1007/s10147-013-0614-x
    By:
    • Ueno, Takayuki;
    • Masuda, Norikazu;
    • Yamanaka, Takeharu;
    • Saji, Shigehira;
    • Kuroi, Katsumasa;
    • Sato, Nobuaki;
    • Takei, Hiroyuki;
    • Yamamoto, Yutaka;
    • Ohno, Shinji;
    • Yamashita, Hiroko;
    • Hisamatsu, Kazufumi;
    • Aogi, Kenjiro;
    • Iwata, Hiroji;
    • Sasano, Hironobu;
    • Toi, Masakazu
    Publication type:
    Article
    16

    Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.

    Published in:
    Oncology Research & Treatment, 2018, v. 41, n. 3, p. 93, doi. 10.1159/000485566
    By:
    • Schochter, Fabienne;
    • Rack, Brigitte;
    • Tzschaschel, Marie;
    • Polasik, Arkadius;
    • Andergassen, Ulrich;
    • Trapp, Elisabeth;
    • Alunni-Fabbroni, Marianna;
    • Schneeweiss, Andreas;
    • Müller, Volkmar;
    • Pantel, Klaus;
    • Gade, Jörg;
    • Lorenz, Ralf;
    • Rezai, Mahdi;
    • Tesch, Hans;
    • Soeling, Ulrike;
    • Fehm, Tanja;
    • Mahner, Sven;
    • Schindlbeck, Christian;
    • Lichtenegger, Werner;
    • Beckmann, Matthias W.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.

    Published in:
    Molecular & Clinical Oncology, 2018, v. 9, n. 3, p. 255, doi. 10.3892/mco.2018.1672
    By:
    • Riccardi, Ferdinando;
    • Colantuoni, Giuseppe;
    • Diana, Anna;
    • Mocerino, Carmela;
    • Cartenì, Giacomo;
    • Lauria, Rossella;
    • Febbraro, Antonio;
    • Nuzzo, Francesco;
    • Addeo, Raffaele;
    • Marano, Ombretta;
    • Incoronato, Pasquale;
    • De Placido, Sabino;
    • Ciardiello, Fortunato;
    • Orditura, Michele
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Neoadjuvant endocrine therapy with exemestane followed by response‐guided combination therapy with low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study

    Published in:
    Cancer Medicine, 2018, v. 7, n. 7, p. 3044, doi. 10.1002/cam4.1600
    By:
    • Sato, Nobuaki;
    • Masuda, Norikazu;
    • Morimoto, Takashi;
    • Ueno, Takayuki;
    • Kanbayashi, Chizuko;
    • Kaneko, Koji;
    • Yasojima, Hiroyuki;
    • Saji, Shigehira;
    • Sasano, Hironobu;
    • Morita, Satoshi;
    • Ohno, Shinji;
    • Toi, Masakazu
    Publication type:
    Article
    40
    41
    42
    43
    44

    Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer.

    Published in:
    BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-239
    By:
    • Yutaka Yamamoto;
    • Takashi Ishikawa;
    • Yasuo Hozumi;
    • Masahiko Ikeda;
    • Hiroji Iwata;
    • Hiroko Yamashita;
    • Tatsuya Toyama;
    • Takashi Chishima;
    • Shigehira Saji;
    • Mutsuko Yamamoto-Ibusuki;
    • Hirotaka Iwase
    Publication type:
    Article
    45
    46
    47
    48
    49
    50